Per Norlen - Xintela AB Chief Officer
| XINT Stock | SEK 0.32 0.01 3.23% |
Insider
Per Norlen is Chief Officer of Xintela AB
| Age | 53 |
| Phone | 46 4 62 75 65 00 |
| Web | https://www.xintela.se |
Xintela AB Management Efficiency
The company has return on total asset (ROA) of (1.1374) % which means that it has lost $1.1374 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (4.6888) %, meaning that it generated substantial loss on money invested by shareholders. Xintela AB's management efficiency ratios could be used to measure how well Xintela AB manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Martin Dahlgren | eEducation Albert AB | 30 | |
| Jeff Borcherding | Immunovia publ AB | N/A | |
| Marie Karlsson | Embellence Group AB | N/A | |
| Stein Yndestad | Norva24 Group AB | 55 | |
| Par Ihrskog | Embellence Group AB | N/A | |
| Sture Stolen | Norva24 Group AB | N/A | |
| Ann Zetterberg | IAR Systems Group | 56 | |
| Haydn Povey | IAR Systems Group | 53 | |
| Karolina LLM | Sedana Medical AB | 44 | |
| Tim Normann | Norva24 Group AB | 59 | |
| Jesper Rydaker | IAR Systems Group | 53 | |
| Peter MD | Sedana Medical AB | 52 | |
| Kajsa Lernestal | eEducation Albert AB | 36 | |
| Clarisa Mogolln | Sedana Medical AB | N/A | |
| Karin Peterson | Clinical Laserthermia Systems | N/A | |
| Linda Frln | Sedana Medical AB | N/A | |
| Jonas Martensson | eEducation Albert AB | 39 | |
| Sven Kristensen | Mekonomen AB | N/A | |
| Johan Skogeryd | KABE Group AB | N/A | |
| Robert Hrd | Mekonomen AB | 57 | |
| Anders Vallenljord | IAR Systems Group | 55 | |
Management Performance
| Return On Equity | -4.69 | |||
| Return On Asset | -1.14 |
Xintela AB Leadership Team
Elected by the shareholders, the Xintela AB's board of directors comprises two types of representatives: Xintela AB inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Xintela. The board's role is to monitor Xintela AB's management team and ensure that shareholders' interests are well served. Xintela AB's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Xintela AB's outside directors are responsible for providing unbiased perspectives on the board's policies.
| BSc JD, Ex Chairman | ||
| Thomas Areschoug, Business Development Manager | ||
| Per Norlen, Chief Officer | ||
| Gunnar Telhammar, CFO Director |
Xintela Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Xintela AB a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -4.69 | |||
| Return On Asset | -1.14 | |||
| Current Valuation | 122.93 M | |||
| Shares Outstanding | 307.57 M | |||
| Shares Owned By Insiders | 58.76 % | |||
| Price To Earning | (4.40) X | |||
| Price To Book | 11.52 X | |||
| Price To Sales | 5,115 X | |||
| Gross Profit | 2.08 M | |||
| EBITDA | (54.43 M) |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Xintela Stock Analysis
When running Xintela AB's price analysis, check to measure Xintela AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xintela AB is operating at the current time. Most of Xintela AB's value examination focuses on studying past and present price action to predict the probability of Xintela AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xintela AB's price. Additionally, you may evaluate how the addition of Xintela AB to your portfolios can decrease your overall portfolio volatility.